Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.7198
+0.0298 (4.32%)
Sep 3, 2026, 11:13 AM EDT - Market open
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $31.31 million as of September 3, 2026. Its market cap has decreased by -21.05% in one year.
Market Cap
31.31M
Enterprise Value
31.16M
1-Year Change
-21.05%
Ranking
Category
Stock Price
$0.72
ChartMarket Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $31.31M, an increase of 1,661.35%. That is a compound annual growth rate of 109.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 31.31M | -46.86% |
| Dec 31, 2025 | 58.91M | 35.70% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lite Strategy | 34.71M |
| Kyntra Bio | 34.13M |
| Actuate Therapeutics | 33.53M |
| Context Therapeutics | 33.51M |
| Quince Therapeutics | 33.13M |
| Actinium Pharmaceuticals | 32.07M |
| NextCure | 31.72M |
| BriaCell Therapeutics | 31.61M |